<SEC-DOCUMENT>0001178913-22-003055.txt : 20220811
<SEC-HEADER>0001178913-22-003055.hdr.sgml : 20220811
<ACCEPTANCE-DATETIME>20220811063034
ACCESSION NUMBER:		0001178913-22-003055
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220811
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220811
DATE AS OF CHANGE:		20220811

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Entera Bio Ltd.
		CENTRAL INDEX KEY:			0001638097
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38556
		FILM NUMBER:		221153548

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT HADASSAH, MINRAV BUILDING
		STREET 2:		FIFTH FLOOR
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			9112002
		BUSINESS PHONE:		972-2-532-7151

	MAIL ADDRESS:	
		STREET 1:		KIRYAT HADASSAH, MINRAV BUILDING
		STREET 2:		FIFTH FLOOR
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			9112002
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>zk2228294.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:entx="http://enterabio.com/20220811" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 22.7.2.5063
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_c5167e284f9c43768cb589b076f42910" contextRef="c20220811to20220811" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:CityAreaCode" id="Fact_7b19734c3ab44be38d1672d8de54d6f3" contextRef="c20220811to20220811">972</ix:nonNumeric><ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_8de1fdfd2d5b425189d1a40be07dcedb" contextRef="c20220811to20220811">97225327151</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_052c143cdc2d409d8fd88c7a08679866" contextRef="c20220811to20220811">0001638097</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_31bd9a85d2d7494f9d77cc9fb47be4ad" contextRef="c20220811to20220811_StatementClassOfStockAxis_OrdinarySharesParValueOfNIS00000769Member">NASDAQ</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_fd031a36d12644b7bede9bcced2b7cdc" contextRef="c20220811to20220811_StatementClassOfStockAxis_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember">NASDAQ</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="entx-20220811.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20220811to20220811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638097</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-11</xbrli:startDate><xbrli:endDate>2022-08-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220811to20220811_StatementClassOfStockAxis_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">entx:WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-11</xbrli:startDate><xbrli:endDate>2022-08-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220811to20220811_StatementClassOfStockAxis_OrdinarySharesParValueOfNIS00000769Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">entx:OrdinarySharesParValueOfNIS00000769Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-11</xbrli:startDate><xbrli:endDate>2022-08-11</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;</div>

    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br />
    </div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">UNITED STATES</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Washington, D.C. 20549</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_2fbdcf785bb54937a9de93482f7cf811" contextRef="c20220811to20220811">8-K</ix:nonNumeric></div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">CURRENT REPORT</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_2cb8b92fe4524f4cb45cbcf1473f1b7c" contextRef="c20220811to20220811" format="ixt:datemonthdayyearen">August 11, 2022</ix:nonNumeric></div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_a5ad8bd69d3e427aaa798cfeff5ebb22" contextRef="c20220811to20220811">Entera Bio Ltd.</ix:nonNumeric><br />
    </div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Exact Name of Registrant as Specified in Its Charter)</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32.01%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_bac787181c4a412398995d1d3f879e77" contextRef="c20220811to20220811" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 2%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 32%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_4d331ce29c164d6f90666ce00750fe9f" contextRef="c20220811to20220811">001-38556</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 2%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 32%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_7c46442cdb4f49e0834015d6ba4deb72" contextRef="c20220811to20220811">00-0000000</ix:nonNumeric><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 32.01%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(State or other jurisdiction<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br />
              </span>of incorporation)</div>
          </td>

    <td style="width: 2%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 32%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Commission File Number)</div>
          </td>

    <td style="width: 2%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 32%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(I.R.S. Employer<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br />
              </span>Identification)</div>
          </td>

  </tr>


</table>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><span style="text-decoration: underline;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_a9a148b0c5a64d0096df741afa5475b7" contextRef="c20220811to20220811">KIRYAT HADASSAH, MINRAV BUILDING</ix:nonNumeric> &#8211; <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_32f02b8733784d289f7b9d46f82fac14" contextRef="c20220811to20220811">FIFTH FLOOR</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_aa501ebb971649f196f00ef3b6f0ca54" contextRef="c20220811to20220811">JERUSALEM</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCountry" id="Fact_214f7a5acc7e4a8e895a22132bf29dac" contextRef="c20220811to20220811" format="ixt-sec:countrynameen">Israel</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_611fbc72545a4de4be8ab23486a6d5cc" contextRef="c20220811to20220811">9112002</ix:nonNumeric></span><br />
      </span>(Address of principal executive offices) (Zip Code)</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-decoration: underline;"><br />
        <span style="-sec-ix-hidden:Fact_7b19734c3ab44be38d1672d8de54d6f3">+972</span><span style="-sec-ix-hidden:Fact_8de1fdfd2d5b425189d1a40be07dcedb">-2-532-7151</span> </span></div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Registrant&#8217;s Telephone Number, Including Area Code)</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;&#160;</div>

    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Former name or former address, if changed since last report)</div>

    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
      under any of the following provisions (see General Instruction A.2. below):</div>

    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_09f12191967d4235b000bed3d5c8b47c" contextRef="c20220811to20220811" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 96.15%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
          </td>

  </tr>


</table>
    <div style="line-height: 1.25;"><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_fa28a6ee372642749beb0beab6dc2e1a" contextRef="c20220811to20220811" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 96.15%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)</div>
          </td>

  </tr>


</table>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_32730146f7ac43dca2e311d8d43f934d" contextRef="c20220811to20220811" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 96.15%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))</div>
          </td>

  </tr>


</table>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_30114007ab1e4cfa8c9efcff2ed36e2d" contextRef="c20220811to20220811" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 96.15%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))</div>
          </td>

  </tr>


</table>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32.01%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Title of each class</div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 32%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Trading Symbol(s)</div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 32%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Name of each exchange on which registered</div>
          </td>

  </tr>

  <tr>

    <td style="width: 32.01%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_ecc368b6f302493aa44f903b0e4f0891" contextRef="c20220811to20220811_StatementClassOfStockAxis_OrdinarySharesParValueOfNIS00000769Member">Ordinary Shares, par value of NIS 0.0000769</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 2%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 32%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_abce1c5968a24ece8c29eef7ce8bbcfb" contextRef="c20220811to20220811_StatementClassOfStockAxis_OrdinarySharesParValueOfNIS00000769Member">ENTX</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 2%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 32%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_31bd9a85d2d7494f9d77cc9fb47be4ad">Nasdaq Capital Market</span><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 32.01%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_6f49ea84c4b6447caaa359c6929dc91b" contextRef="c20220811to20220811_StatementClassOfStockAxis_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember">Warrants, each Warrant exercisable for half of an Ordinary Share at an exercise price of $5.85 per Ordinary Share</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 2%; vertical-align: top; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 32%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_edfc66dc46a04b07800c800ffa78b6ee" contextRef="c20220811to20220811_StatementClassOfStockAxis_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember">ENTXW</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 2%; vertical-align: top; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 32%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_fd031a36d12644b7bede9bcced2b7cdc">Nasdaq Capital Market</span><br />
            </div>
          </td>

  </tr>


</table>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933
      (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_a2766478bc9c48f4a49c2bdf22c498a1" contextRef="c20220811to20220811" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric></div>

    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br />
    </div>

    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
      complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric name="dei:EntityExTransitionPeriod" id="Fact_e88092291076462baba0732c3b559885" contextRef="c20220811to20220811" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;</div>

    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 2.02 Results of Operations and Financial Condition.</div>

      <div style="line-height: 1.25">&#160;</div>

      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On August 11, 2022, Entera Bio Ltd., a company organized under the laws of the State of Israel (&#8220;we,&#8221; &#8220;us,&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221;),
        issued a press release announcing its financial results for the three and six months ended June 30, 2022. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item 2.02.</div>

      <div style="line-height: 1.25">&#160;</div>

      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 7.01 Regulation FD Disclosure.</div>

      <div style="line-height: 1.25">&#160;</div>

      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The information contained in Item 2.02 of this Current Report on Form 8-K is incorporated by reference in this Item 7.01.</div>

      <div style="line-height: 1.25">&#160;</div>

      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The information contained in this Current Report on Form 8-K, including in Exhibit 99.1 attached hereto, is &#8220;furnished&#8221; and not
        &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference in another filing under the
        Exchange Act or the Securities Act of 1933, as amended, except to the extent such other filing specifically incorporates such information by reference.</div>

      <div style="line-height: 1.25">&#160;</div>

      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 9.01 Financial Statements and Exhibits.</div>

      <div style="line-height: 1.25">&#160;</div>

      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d) Exhibits.</div>

      <div style="line-height: 1.25;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 8.66%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Number</div>
            </td>

    <td style="width: 0.44%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td style="width: 90.9%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Description</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.66%; vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="exhibit_99-1.htm">99.1</a></div>
            </td>

    <td style="width: 0.44%; vertical-align: bottom;"><br />
            </td>

    <td style="width: 90.9%; vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="exhibit_99-1.htm">Press Release dated
                  August 11, 2022 announcing the Company&#8217;s financial results for the three and six months ended June 30, 2022.</a></div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.66%; vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">104</div>
            </td>

    <td style="width: 0.44%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90.9%; vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
            </td>

  </tr>


</table>
      <div style="line-height: 1.25;"><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      </div>

      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"> <br />
      </div>

      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
        behalf by the undersigned thereunto duly authorized.</div>

      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 51.56%; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="width: 3.11%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
              <div style="text-align: justify; line-height: 1.25;">ENTERA BIO LTD.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 51.56%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="width: 3.11%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="width: 45.33%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 51.56%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
              <div style="text-align: justify; line-height: 1.25;">Date: August 11, 2022</div>
            </td>

    <td style="width: 3.11%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
              <div style="text-align: justify; line-height: 1.25;">By:</div>
            </td>

    <td style="width: 45.33%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
              <div style="text-align: justify; line-height: 1.25;">/s/ Miranda J. Toledano</div>
            </td>

  </tr>

  <tr>

    <td style="width: 51.56%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="width: 3.11%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="width: 45.33%; vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Name: Miranda J. Toledano</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Title: Chief Executive Officer</div>
            </td>

  </tr>


</table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

      <div><span style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> </span></div>
</div>

  </div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 22.7.2.5063
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 99.1</font></u></div>
    <div style="line-height: 1.25;">
      <div style="text-align: left; line-height: 1.25;"><img width="136" height="100" src="image0.jpg"></div>
    </div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Entera

      Bio Provides Business Highlights and Financial Results for the Second Quarter 2022</div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">JERUSALEM &#8211; August 11, 2022 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (&#8220;Entera&#8221; or the &#8220;Company&#8221;) a leader in the development
      of orally delivered peptides and therapeutic proteins, today announced its financial and operating results for the quarter ended June 30, 2022.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;We have reset our thesis and executed on several critical milestones in the first half of 2022. On July 18th, we announced the
      submission of our proposed registrational protocol for EB613 to the U.S. Food and Drug Administration (FDA). We are simultaneously finalizing the validation of an optimized formulation of EB612, while expanding our pre-clinical pipeline with
      additional anti-inflammatory and metabolic protein candidates. Lastly, we finished the quarter with $17.3 million in cash which, given our revised Phase 3 schedule, is projected to fund our current operations through the first half of 2023.&#8221;
      commented Ms. Miranda Toledano, Chief Executive Officer of the Company. &#8220;I am incredibly energized by the opportunities ahead. By continuing to carry forward our internal clinical programs and strategic dialogues, we are poised to deliver tremendous
      value to patients and our shareholders as we reshape the future of Entera. We look forward to providing a comprehensive update to the investment community later this year.&#8221;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Business Highlights:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Entera expects to hold a Type C Meeting with the FDA to discuss the potential registrational study for its lead clinical asset, EB613 in
      the second half of 2022. The Phase 3 is designed as an 18 month double blind placebo-controlled study using FNIH-BQP<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup> total hip Bone Mineral Density (BMD) thresholds as the primary endpoint to evaluate fracture risk, followed by a 6-month
      open label transition to alendronate.&#160; EB613 is the first oral formulation of PTH (1-34), teriparatide, and the first proposed oral anabolic (bone forming) drug candidate to treat post-menopausal women with osteoporosis. EB613 has the same amino acid
      sequence as Forteo<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> which requires daily subcutaneous injections and reported peak sales surpassing $1.7 billion in 2017, prior to patent expiry.&#160; According to early commercial assessments and clinician surveys, it is estimated that less
      than 10% of osteoporosis patients use current anabolic drugs (including PTH receptor activators currently available such as Forteo<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> and Tymlos<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>). Despite the validated mechanism of action of these treatments, patients are
      deterred by their high cost and injectable mode of administration. As the first oral PTH receptor activator EB613 is expected to address this significant unmet clinical need.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Additionally, Entera is finalizing the development of an optimized formulation for EB612 which may enable twice a day administration
        (versus the previous 4 times a day) to patients with hypoparathyroidism. The Company anticipates conducting a first-in-human PK study of the new formulation in the first half of 2023. Entera previously conducted a pilot 4-month Phase 2 study,
        results of which were presented (ASBMR 2015) and published in a peer-reviewed journal (JBMR 2021), as well as a Phase 2 PK-PD study versus Natpara,<sup style="font-family: Symbol, serif; vertical-align: text-top; line-height: 1; font-size: smaller;">&#210;</sup><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font>whose findings have also been publicly presented (ASBMR 2019). These studies demonstrated that EB612 induced a rapid decline in median serum phosphate levels and maintenance of target calcium levels throughout the
        study, even as patients were able to meaningfully reduce their calcium and active vitamin D supplementation which is key to reducing common comorbidities of this disease.</div>
    </div>
    <div style="line-height: 1.25;"><br>
      <hr noshade="noshade" align="left" style="text-align: left; background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;">
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><sup style="font-family: Calibri, sans-serif; vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;Foundation

          for the National Institutes of Health Bone Quality Program (FNIH BQP)</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Finally, Entera announced the formation of its Clinical and Scientific Advisory Board (CSAB), comprising world class experts in bone
      diseases, endocrinology, and metabolic disorders and will be presenting incremental data from its 6-month&#160;Oral PTH (EB613)&#160;Phase 2 Study in postmenopausal women with low bone mass, at the&#160;2022 Annual Meeting of the&#160;American Society for Bone and
      Mineral Research (ASBMR), which will take place in Austin, Texas from September 9-12, 2022.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Financial Results for the Six-Month Period Ended June 30, 2022</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Revenues for the six months ended June 30, 2022 were $112,000 compared to $226,000 for the six months ended June 30, 2021. In this
      period, the majority of our revenues were attributable to research and development, or R&amp;D services provided to Amgen under our 2018 collaboration agreement. The cost of revenues for the six months ended June 30, 2022 were $87,000 compared to
      $172,000 for the six months ended June 30, 2021 and were primarily attributed to salaries and related expenses in connection with the R&amp;D services provided to Amgen.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Operating expenses for the six months ended June 30, 2022 were $7.1 million compared to $5.0 million for the six months ended June 30,
      2021. Entera&#8217;s operating loss was $7.1 million for the six months ended June 30, 2022, compared to $4.9 million for the six months ended June 30, 2021.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Research and development expenses for the six months ended June 30, 2022 were $3.1 million, compared to $2.4 million for the six months
      ended June 30, 2021, an increase of $0.7 million. The increase was primarily due to an increase of $0.7 in materials and production costs and pre-clinical activity as part of the preparation for our Phase 3 clinical trial for EB613 and an increase of
      $0.4 million in employee's compensation. The increase was partially offset by a decrease of $0.4 million in other clinical trial expenses related to our Phase 2 trial for EB613 that was completed in June 2021.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">General and administrative expenses for the six months ended June 30, 2022 were $4.1 million, compared to $2.7 million for the six
      months ended June 30, 2021, an increase of $1.4 million. The increase of $1.4 million was mainly attributable to an increase of $0.8 million in share-based compensation granted to non-executive directors and employees, an increase of $0.4 million in
      legal, accounting fees and others consultants and an increase of $0.2 million in D&amp;O insurance costs.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The net comprehensive loss was $7.0 million or $0.24 per ordinary share (basic and diluted) for the six months ended June 30, 2022,
      compared to $4.9 million, or $0.21 per ordinary share (basic and diluted) for the six months ended June 31, 2021.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">As of June 30, 2022, Entera had cash and cash equivalents of $17.3 million, compared to $20.1 million as of March 31, 2021.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Entera expects that the current cash is sufficient to fund the operations through the second quarter of 2023.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">About EB613 (a.k.a. EBP05)</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Parathyroid hormone (PTH) is an 84-amino acid hormone and
        the primary regulator of calcium and phosphate metabolism in bone and kidney. EB613 is an oral formulation of synthetic hPTH (1-34), (teriparatide), a peptide consisting of the first 34 amino acids of PTH which represent the functional region.&#160;
        Subcutaneous Forteo</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174; </sup><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(teriparatide injection) has been the leading anabolic treatment of osteoporosis since 2002. EB613 utilizes Entera&#8217;s oral drug
        delivery platform which promotes enteric absorption and stabilizes teriparatide in the gastrointestinal tract. Entera&#8217;s Oral PTH formulations have been administered collectively to a total of 225 subjects in two Phase 1 studies and 3 phase 2
        studies (including 35 in 2 phase 2 hypoparathyroidism studies). The most recent study was a dose ranging Phase 2 study in postmenopausal women with low bone mass. This study met primary and key secondary endpoints and was presented in a
        late-breaker oral presentation at the ASBMR 2021 conference. For the primary efficacy endpoint: a statistically significant increase in P1NP (a bone formation marker) at 3 months was achieved. A significant dose response was observed for 0.5, 1.0,
        1.5 and 2.5 mg oral PTH doses on P1NP, Osteocalcin and bone mineral density (BMD). Subjects receiving the 2.5 mg dose of EB613 showed significant increases in dose-related BMD at the lumbar spine, total hip, and femoral neck at 6 months. Subjects
        receiving the 2.5 mg dose of EB613 daily for 6 months had a significant placebo adjusted increase of 3.78% in lumbar spine BMD (p&lt;0.008) which is similar to the 3.9% increase in lumbar spine BMD seen with Forteo</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> in clinical studies reported in the literature. Increases in total hip and femoral neck BMD were greater than those previously reported with Forteo</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">. EB613 exhibited an excellent safety profile, with no drug related serious adverse events. </font>&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">The


        most common adverse events included mild nausea, moderate back pain, moderate headache, and moderate upper abdominal pain.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">About Entera Bio</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Entera is a leader in the development of orally delivered
        macromolecules therapeutics including peptides and other therapeutic proteins, for use in areas with significant unmet medical need where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients.
        The Company&#8217;s proprietary, oral drug delivery technology is designed to address the technical challenges of poor absorption, high variability, and the inability to deliver large molecules to the targeted location in the body through the use of a
        synthetic absorption enhancer to facilitate the absorption of large molecules, and protease inhibitors to prevent enzymatic degradation and support delivery to targeted tissues. The Company&#8217;s most advanced product candidates, EB613 for the
        treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are in clinical development. The Company recently completed the phase 2 study for EB613 and has a Type C meeting scheduled with FDA with respect to its Phase 3 program in
        H2 2022. Entera also licenses its technology to biopharmaceutical companies for use with their proprietary compounds and, to date, has established a collaboration with Amgen Inc. For more information on Entera Bio, visit <u>www.enterabio.com</u>.</font></div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Contact:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Entera Bio:</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ms. Miranda Toledano</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Chief Executive Officer</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Entera Bio</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Email: <u>miranda@enterabio.com</u></font></div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Phone: +972-58-55-88-470</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">IR:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Mr. Christopher M. Calabrese</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Managing Director</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">LifeSci Advisors LLC</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Email: <u>ccalabrese@lifesciadvisors.com</u></font></div>
    <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Phone: (917) 680-5608<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
        </font></font><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Cautionary Statement Regarding Forward Looking Statements</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Various statements in this press release are &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform
      Act of 1995. All statements (other than statements of historical facts) in this press release regarding our prospects, plans, financial position, business strategy and expected financial and operational results may constitute forward-looking
      statements. Words such as, but not limited to, &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;can,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;design,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;objective,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;target,&#8221; &#8220;likely,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; and &#8220;would,&#8221; or
      the negative of these terms and similar expressions or words, identify forward-looking statements. Forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties.
      Forward-looking statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or results will be achieved.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Important factors that could cause actual results to differ materially from those reflected in Entera&#8217;s forward-looking statements
      include, among others: changes in the interpretation of clinical data; results of our clinical trials; the FDA&#8217;s interpretation and review of our results from and analysis of our clinical trials; unexpected changes in our ongoing and planned
      preclinical development and clinical trials, the timing of and our ability to make regulatory filings and obtain and maintain regulatory approvals for our product candidates; the potential disruption and delay of manufacturing supply chains; loss of
      available workforce resources, either by Entera or its collaboration and laboratory partners; impacts to research and development or clinical activities that Entera is contractually obligated to provide, such as those pursuant to Entera&#8217;s agreement
      with Amgen; overall regulatory timelines; the size and growth of the potential markets for our product candidates; the scope, progress and costs of developing Entera&#8217;s product candidates; Entera&#8217;s reliance on third parties to conduct its clinical
      trials; Entera&#8217;s expectations regarding licensing, business transactions and strategic collaborations; Entera&#8217;s operation as a development stage company with limited operating history; Entera&#8217;s ability to continue as a going concern absent access to
      sources of liquidity; Entera&#8217;s ability to obtain and maintain regulatory approval for any of its product candidates; Entera&#8217;s ability to comply with Nasdaq&#8217;s minimum listing standards and other matters related to compliance with the requirements of
      being a public company in the United States; Entera&#8217;s intellectual property position and its ability to protect its intellectual property; and other factors that are described in the &#8220;Cautionary Statements Regarding Forward-Looking Statements,&#8221; &#8220;Risk
      Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; sections of Entera&#8217;s most recent Annual Report on Form 10-K filed with the SEC, as well as the company&#8217;s subsequently filed Quarterly Reports on Form
      10-Q and Current Reports on Form 8-K.&#160; There can be no assurance that the actual results or developments anticipated by Entera will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on,
      Entera. Therefore, no assurance can be given that the outcomes stated or implied in such forward-looking statements and estimates will be achieved. Entera cautions investors not to rely on the forward-looking statements Entera makes in this press
      release. The information in this press release is provided only as of the date of this press release, and Entera undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future
      events or otherwise, except to the extent required by law.</div>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div style="page-break-after: always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div><br>
    <table cellspacing="0" cellpadding="0" id="z71479dcd511545e1868b89b33107c696" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 100%; vertical-align: middle;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><font style="line-height: 1.25;">&#160;</font>ENTERA BIO LTD.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: middle;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">CONSOLIDATED BALANCE SHEETS</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: middle;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(U.S. dollars in thousands, except share data)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: middle;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Unaudited)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z622b57557a084cff8efb69246b0858a4" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: middle;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"> June 30</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">December 31</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"> 2022</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle;" colspan="6">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cash and cash equivalents</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">17,279</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">24,892</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 76%;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Accounts receivable and other current assets</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,147</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">437</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Property and equipment, net</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">166</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">156</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 76%;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Other assets, net</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">496</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">502</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Total assets</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">19,088</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">25,987</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 76%;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Accounts payable and other current liabilities</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,692</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3,161</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 76%;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Total non current liabilities</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">127</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">261</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Total liabilities</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,819</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3,422</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 76%;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Total shareholders' equity</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">17,269</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">22,565</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 76%; padding-bottom: 4px;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Total liabilities and shareholders' equity</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">19,088</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">25,987</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">ENTERA BIO LTD.</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
      </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">CONSOLIDATED STATEMENTS OF OPERATIONS</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
      </font>(U.S. dollars in thousands, except share and per share data)</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="za53ce82f5b19443bb2fb85144b7e6570" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">SIX Months ended June 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"> 202<font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">2</font></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">REVENUES</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">112</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">266</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">COST OF REVENUES</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">87</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">172</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">GROSS PROFIT</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">25</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">94</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">OPERATING EXPENSES:</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt; margin-left: 18pt;">Research and development</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3,084</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2,351</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt; margin-left: 18pt;">General and administrative</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4,052</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2,674</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt; margin-left: 18pt;">Other income</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(27</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(22</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">TOTAL OPERATING EXPENSES</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">7,109</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">5,003</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">OPERATING LOSS</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">7,084</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4,909</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">FINANCIAL EXPENSES (INCOME),&#160;net</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(104</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(5</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">LOSS BEFORE INCOME TAX</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">6,980</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4,904</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">INCOME TAX <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#1464;</font>(BENEFIT)
              EXPENSE</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(11</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(31</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">NET LOSS</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">6,969</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4,873</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">LOSS PER SHARE BASIC AND DILUTED</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">0.24</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">0.21</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">WEIGHTED-AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF BASIC AND DILUTED LOSS PER SHARE</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">28,806,217</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">23,377,668</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>entx-20220811.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5063 Broadridge-->
<xs:schema targetNamespace="http://enterabio.com/20220811" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:entx="http://enterabio.com/20220811" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="entx-20220811_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="entx-20220811_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="entx-20220811_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://enterabio.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xs:element name="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" id="entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OrdinarySharesParValueOfNIS00000769Member" id="entx_OrdinarySharesParValueOfNIS00000769Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>entx-20220811_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5063 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://enterabio.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="entx-20220811.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://enterabio.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="definition: EntityListingsLineItems to DocumentType" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="definition: EntityListingsLineItems to AmendmentFlag" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="definition: EntityListingsLineItems to DocumentPeriodEndDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="definition: EntityListingsLineItems to EntityRegistrantName" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="definition: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="definition: EntityListingsLineItems to EntityFileNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="definition: EntityListingsLineItems to EntityTaxIdentificationNumber" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine2" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine3" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="definition: EntityListingsLineItems to EntityAddressCityOrTown" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="definition: EntityListingsLineItems to EntityAddressStateOrProvince" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="definition: EntityListingsLineItems to EntityAddressCountry" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="definition: EntityListingsLineItems to EntityAddressPostalZipCode" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="definition: EntityListingsLineItems to CityAreaCode" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="definition: EntityListingsLineItems to LocalPhoneNumber" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="definition: EntityListingsLineItems to WrittenCommunications" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="definition: EntityListingsLineItems to SolicitingMaterial" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementTenderOffer" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="definition: EntityListingsLineItems to NoTradingSymbolFlag" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="definition: EntityListingsLineItems to EntityEmergingGrowthCompany" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="definition: EntityListingsLineItems to EntityExTransitionPeriod" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalYearFocus" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="definition: EntityListingsLineItems to EntityCentralIndexKey" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="definition: EntityListingsLineItems to Security12bTitle" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="definition: EntityListingsLineItems to TradingSymbol" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="definition: EntityListingsLineItems to SecurityExchangeName" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EntityListingsLineItems" xlink:to="EntityListingsTable" xlink:title="definition: EntityListingsLineItems to EntityListingsTable" order="30.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: EntityListingsTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="entx-20220811.xsd#entx_OrdinarySharesParValueOfNIS00000769Member" xlink:label="OrdinarySharesParValueOfNIS00000769Member" xlink:title="OrdinarySharesParValueOfNIS00000769Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="OrdinarySharesParValueOfNIS00000769Member" xlink:title="definition: ClassOfStockDomain to OrdinarySharesParValueOfNIS00000769Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="entx-20220811.xsd#entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:label="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:title="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:title="definition: ClassOfStockDomain to WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" order="2.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>entx-20220811_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5063 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockDomain_lbl">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis_lbl">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:label xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US" id="dei_EntityExTransitionPeriod_lbl">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:title="label: EntityExTransitionPeriod to dei_EntityExTransitionPeriod_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsTable_lbl" xml:lang="en-US" id="dei_EntityListingsTable_lbl">Entity Listings [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsTable" xlink:to="dei_EntityListingsTable_lbl" xlink:title="label: EntityListingsTable to dei_EntityListingsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsLineItems_lbl" xml:lang="en-US" id="dei_EntityListingsLineItems_lbl">Entity Listings [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsLineItems" xlink:to="dei_EntityListingsLineItems_lbl" xlink:title="label: EntityListingsLineItems to dei_EntityListingsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
    <link:loc xlink:type="locator" xlink:href="entx-20220811.xsd#entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:label="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:title="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" />
    <link:label xlink:type="resource" xlink:label="entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember_lbl1" xml:lang="en-US" id="entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember_lbl1">Warrants, each Warrant exercisable for half of an Ordinary Share at an exercise price of $5.85 per Ordinary Share [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:to="entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember_lbl1" xlink:title="label: WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember to entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="entx-20220811.xsd#entx_OrdinarySharesParValueOfNIS00000769Member" xlink:label="OrdinarySharesParValueOfNIS00000769Member" xlink:title="OrdinarySharesParValueOfNIS00000769Member" />
    <link:label xlink:type="resource" xlink:label="entx_OrdinarySharesParValueOfNIS00000769Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="entx_OrdinarySharesParValueOfNIS00000769Member_lbl1" xml:lang="en-US" id="entx_OrdinarySharesParValueOfNIS00000769Member_lbl1">Ordinary Shares, par value of NIS 0.0000769 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrdinarySharesParValueOfNIS00000769Member" xlink:to="entx_OrdinarySharesParValueOfNIS00000769Member_lbl1" xlink:title="label: OrdinarySharesParValueOfNIS00000769Member to entx_OrdinarySharesParValueOfNIS00000769Member_lbl1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>entx-20220811_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5063 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://enterabio.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="entx-20220811.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://enterabio.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="entx-20220811.xsd#entx_OrdinarySharesParValueOfNIS00000769Member" xlink:label="OrdinarySharesParValueOfNIS00000769Member" xlink:title="OrdinarySharesParValueOfNIS00000769Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="OrdinarySharesParValueOfNIS00000769Member" xlink:title="presentation: ClassOfStockDomain to OrdinarySharesParValueOfNIS00000769Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="entx-20220811.xsd#entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:label="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:title="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:title="presentation: ClassOfStockDomain to WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: EntityListingsTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="presentation: EntityListingsLineItems to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="presentation: EntityListingsLineItems to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: EntityListingsLineItems to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityListingsLineItems to EntityRegistrantName" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="presentation: EntityListingsLineItems to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: EntityListingsLineItems to EntityTaxIdentificationNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine2" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine3" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: EntityListingsLineItems to EntityAddressCityOrTown" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: EntityListingsLineItems to EntityAddressStateOrProvince" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="presentation: EntityListingsLineItems to EntityAddressCountry" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: EntityListingsLineItems to EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="presentation: EntityListingsLineItems to CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="presentation: EntityListingsLineItems to LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="presentation: EntityListingsLineItems to WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="presentation: EntityListingsLineItems to SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: EntityListingsLineItems to NoTradingSymbolFlag" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: EntityListingsLineItems to EntityEmergingGrowthCompany" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="presentation: EntityListingsLineItems to EntityExTransitionPeriod" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalYearFocus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityListingsLineItems to EntityCentralIndexKey" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="presentation: EntityListingsLineItems to Security12bTitle" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="presentation: EntityListingsLineItems to TradingSymbol" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="presentation: EntityListingsLineItems to SecurityExchangeName" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="EntityListingsLineItems" xlink:title="presentation: EntityListingsTable to EntityListingsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityListingsTable" xlink:title="presentation: CoverAbstract to EntityListingsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ": -8# 2(  A$! Q$!_\0
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M*PR&!R#3J@LX#;6<4+,&*+C(%3T %%%% !1110 4444 %%%% !1110 4444
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MA( R3Q7&MJ/BC4O^/:U-NA[A-O'U;^E1'PMK5Z0UY>)]))6<C^GZUSO%R?\
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<@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139661658304160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 11, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 11,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Entera Bio Ltd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38556<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">KIRYAT HADASSAH, MINRAV BUILDING<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">FIFTH FLOOR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">JERUSALEM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">9112002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">97225327151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001638097<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=entx_OrdinarySharesParValueOfNIS00000769Member', window );">Ordinary Shares, par value of NIS 0.0000769 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares, par value of NIS 0.0000769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ENTX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember', window );">Warrants, each Warrant exercisable for half of an Ordinary Share at an exercise price of $5.85 per Ordinary Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants, each Warrant exercisable for half of an Ordinary Share at an exercise price of $5.85 per Ordinary Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ENTXW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=entx_OrdinarySharesParValueOfNIS00000769Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=entx_OrdinarySharesParValueOfNIS00000769Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>zk2228294_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:entx="http://enterabio.com/20220811"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="entx-20220811.xsd" xlink:type="simple"/>
    <context id="c20220811to20220811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <startDate>2022-08-11</startDate>
            <endDate>2022-08-11</endDate>
        </period>
    </context>
    <context id="c20220811to20220811_StatementClassOfStockAxis_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">entx:WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-11</startDate>
            <endDate>2022-08-11</endDate>
        </period>
    </context>
    <context id="c20220811to20220811_StatementClassOfStockAxis_OrdinarySharesParValueOfNIS00000769Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">entx:OrdinarySharesParValueOfNIS00000769Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-11</startDate>
            <endDate>2022-08-11</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20220811to20220811"
      id="Fact_c5167e284f9c43768cb589b076f42910">false</dei:AmendmentFlag>
    <dei:CityAreaCode
      contextRef="c20220811to20220811"
      id="Fact_7b19734c3ab44be38d1672d8de54d6f3">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20220811to20220811"
      id="Fact_8de1fdfd2d5b425189d1a40be07dcedb">97225327151</dei:LocalPhoneNumber>
    <dei:EntityCentralIndexKey
      contextRef="c20220811to20220811"
      id="Fact_052c143cdc2d409d8fd88c7a08679866">0001638097</dei:EntityCentralIndexKey>
    <dei:SecurityExchangeName
      contextRef="c20220811to20220811_StatementClassOfStockAxis_OrdinarySharesParValueOfNIS00000769Member"
      id="Fact_31bd9a85d2d7494f9d77cc9fb47be4ad">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="c20220811to20220811_StatementClassOfStockAxis_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember"
      id="Fact_fd031a36d12644b7bede9bcced2b7cdc">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20220811to20220811"
      id="Fact_2fbdcf785bb54937a9de93482f7cf811">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20220811to20220811"
      id="Fact_2cb8b92fe4524f4cb45cbcf1473f1b7c">2022-08-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20220811to20220811"
      id="Fact_a5ad8bd69d3e427aaa798cfeff5ebb22">Entera Bio Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20220811to20220811"
      id="Fact_bac787181c4a412398995d1d3f879e77">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20220811to20220811"
      id="Fact_4d331ce29c164d6f90666ce00750fe9f">001-38556</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20220811to20220811"
      id="Fact_7c46442cdb4f49e0834015d6ba4deb72">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20220811to20220811"
      id="Fact_a9a148b0c5a64d0096df741afa5475b7">KIRYAT HADASSAH, MINRAV BUILDING</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20220811to20220811"
      id="Fact_32f02b8733784d289f7b9d46f82fac14">FIFTH FLOOR</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20220811to20220811"
      id="Fact_aa501ebb971649f196f00ef3b6f0ca54">JERUSALEM</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="c20220811to20220811"
      id="Fact_214f7a5acc7e4a8e895a22132bf29dac">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="c20220811to20220811"
      id="Fact_611fbc72545a4de4be8ab23486a6d5cc">9112002</dei:EntityAddressPostalZipCode>
    <dei:WrittenCommunications
      contextRef="c20220811to20220811"
      id="Fact_09f12191967d4235b000bed3d5c8b47c">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20220811to20220811"
      id="Fact_fa28a6ee372642749beb0beab6dc2e1a">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20220811to20220811"
      id="Fact_32730146f7ac43dca2e311d8d43f934d">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20220811to20220811"
      id="Fact_30114007ab1e4cfa8c9efcff2ed36e2d">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20220811to20220811_StatementClassOfStockAxis_OrdinarySharesParValueOfNIS00000769Member"
      id="Fact_ecc368b6f302493aa44f903b0e4f0891">Ordinary Shares, par value of NIS 0.0000769</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20220811to20220811_StatementClassOfStockAxis_OrdinarySharesParValueOfNIS00000769Member"
      id="Fact_abce1c5968a24ece8c29eef7ce8bbcfb">ENTX</dei:TradingSymbol>
    <dei:Security12bTitle
      contextRef="c20220811to20220811_StatementClassOfStockAxis_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember"
      id="Fact_6f49ea84c4b6447caaa359c6929dc91b">Warrants, each Warrant exercisable for half of an Ordinary Share at an exercise price of $5.85 per Ordinary Share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20220811to20220811_StatementClassOfStockAxis_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember"
      id="Fact_edfc66dc46a04b07800c800ffa78b6ee">ENTXW</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20220811to20220811"
      id="Fact_a2766478bc9c48f4a49c2bdf22c498a1">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="c20220811to20220811"
      id="Fact_e88092291076462baba0732c3b559885">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MJN#PYMW#6P3BN( X1E4\( ASBGY$%U44>/LYC11#.%H%1VN_8HR8Y,(,KI#
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M_#S[A4Q8D(%C5P\'7.D;^@\C+Y/%P0,!YE5HYOSD.9Z)2@>O$;@>3O_ 2,I
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M              "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( ,LS"U4D'INBK0   /@!   :
M          "  :D2  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( ,LS"U5ED'F2&0$  ,\#   3              "  8X3  !;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  -@4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="zk2228294.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://enterabio.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="zk2228294.htm">zk2228294.htm</File>
    <File>entx-20220811.xsd</File>
    <File>entx-20220811_def.xml</File>
    <File>entx-20220811_lab.xml</File>
    <File>entx-20220811_pre.xml</File>
    <File>exhibit_99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "zk2228294.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "entx-20220811_def.xml"
     ]
    },
    "inline": {
     "local": [
      "zk2228294.htm"
     ]
    },
    "labelLink": {
     "local": [
      "entx-20220811_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "entx-20220811_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "entx-20220811.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 36,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 6,
    "total": 6
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "entx",
   "nsuri": "http://enterabio.com/20220811",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2228294.htm",
      "contextRef": "c20220811to20220811",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://enterabio.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2228294.htm",
      "contextRef": "c20220811to20220811",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityListingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Listings [Line Items]"
       }
      }
     },
     "localname": "EntityListingsLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container for exchange listing information for an entity",
        "label": "Entity Listings [Table]"
       }
      }
     },
     "localname": "EntityListingsTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "entx_OrdinarySharesParValueOfNIS00000769Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary Shares, par value of NIS 0.0000769 [Member]"
       }
      }
     },
     "localname": "OrdinarySharesParValueOfNIS00000769Member",
     "nsuri": "http://enterabio.com/20220811",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants, each Warrant exercisable for half of an Ordinary Share at an exercise price of $5.85 per Ordinary Share [Member]"
       }
      }
     },
     "localname": "WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember",
     "nsuri": "http://enterabio.com/20220811",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001178913-22-003055-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-22-003055-xbrl.zip
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MR+<N9YD7.6EAE@O=U!_T/6$^G5^&\^8'KG;E:O /,68MH*)W5O\"FA\U,-1
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MO!3/C!R-_S'[$>6B S_+Q[0ZM'Q&94A5Y?8I/J!#\UC>TD>&Q;/R'UY7,QH
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M[.\^%>;XAK\2?RTP:_+3OZXW_1-02P,$%     @ RS,+5<\BIU];!P  ]U
M !4   !E;G1X+3(P,C(P.#$Q7W!R92YX;6S57%USVC@4?=^9_0\L?>9[DY9,
MTPZ;)BVS:6 "N]W=EXZP!6AJ+$82#?GW*QF)(EFV92!4Y"$AUO'5/?<>??AB
M^^W[]2*J?(>$(AQ?5UOU9K4"XP"'*)Y=5U>T!FB 4/7]NU]_>?M;K?81QI
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M;2,5)YZ-;^+E@YL6\4N\K._=_U!+ P04    " #+,PM53R@#D ,D  #$7P$
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M[(*'D3,EN YQIV,%UH12<2KV;:U=V4=T.;AB&B$<XWHMP,@(6,>CQ0;B7B+
M;\8\!,)FH06CQ8XH,: &F/Q/845DC+%AC&P"CUAQ$*#YI5G&]T*8';3$:+R<
M'O8KFL/-]BW?19Z&82]A-Y<29+_-V9WO")M[?HF=C*4 "!,9PD+9]7 (1F&
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M!RHD73T&C,#"PI0[D=>JWY&5E4%'JGAB8%"CUA/<([)#M@N:U8EI?4A+@;#
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M-(S,Q4SZFUQ;E*CD(@>1B?7 32H3H3>&4M#DB9*'(YPID_(G7WEF78D8JV8
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M DZGH]%MB:;I"0T0B>I2]CR9@]6*+(,R99&H(D98A@-&8;:,EGH89*,[L;*
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M+\_LEVJMC9U6*;)L7XP_%=/T,GTO7U 'YT=2Y$8&Y(N[:_4<Q!8*=ZR@S,7
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M'L?1U_R$5<C<;A)C'CRT;N>HK"\L]N)-RO:BJ;:%GB= K>75]2?FIF^;W/?
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MUFY ;.5!""!UT-5<(+4CD).B8$5WV!&PO!G[Q\'_38A6<IR=HY4,6N<(SS6
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M9 BZIM38"7^8LW"8)=?)[P_.Q?X"/<L3VW@O*#?PR],]%P?^?#R'7YH+ +*
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MJA@'7@A/++!/ VWM",!#PNF*NM)_1&5JITN<XBREXIDXF&>"_X2G7YISHJH
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M>"TR,#(R,#@Q,5]D968N>&UL4$L! A0#%     @ RS,+54=T0T;5"@  J'
M !4              ( !N0L  &5N='@M,C R,C X,3%?;&%B+GAM;%!+ 0(4
M Q0    ( ,LS"U7/(J=?6P<  /=0   5              "  <$6  !E;G1X
M+3(P,C(P.#$Q7W!R92YX;6Q02P$"% ,4    " #+,PM53R@#D ,D  #$7P$
M$               @ %/'@  97AH:6)I=%\Y.2TQ+FAT;5!+ 0(4 Q0    (
M ,LS"U4]^EK%0A0  '^,   -              "  8!"  !Z:S(R,C@R.30N
9:'1M4$L%!@     &  8 @0$  .U6      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
